Jessica Menis retweeted
HUGE news. Perhaps one of the most important top line results for a common solid tumor. Looking forward to the data @OncoAlert
🚨🔥‼️@OncoAlert Hot off the press.
#BigNews #PressRelease by @Amgen
⭐️ #DeLLphi305 phase 3 trial of:
❇️1st line maintenance #Tarlatamab + #Durvalumab) vs #Durvalumab alone in patients with #ExtensiveStage #SmallCell #LungCancer after initial induction Tx with Chemo + Durvalumab.
Showed:
✅Statistically Significant & Clinically meaningful ⬆️#OverallSurvival (#OS) Benefit.
👇🏻
tinyurl.com/ytxbe2xf
Jessica Menis retweeted
#SCLC therapeutic landscape is rapidly changing, with T-cell engagers, ADCs and bi-specifics moving fast to earlier lines of treatment and challenging the current treatment paradigm
Thrilled to discuss the landscape with KOLs @peters_solange and @nicogirardcurie in a brain-storming discussion
Follow the link below to access:
#some #LCSM @SclcSMASHERS
@LUNGevity @LungCancerEu
MCCR2026 at the start!! Another exciting workshop in clinical trial research. One protocol in one week!
@lillian_siu @drcmassard @BenjaminBesseMD @giannatempopatr @EORTC @myESMO @AACR
Jessica Menis retweeted
With #ASCO26 just around the corner, it is my great pleasure to present in the oral abstract session, alongside prominent colleagues and chairs, the intracranial efficacy data of #tarlatamab from #DeLLphi-304 trial, the first data on CNS efficacy of a T-cell engager in #SCLC. Stay tuned!!
📌 Sunday June 1st, 13:15-16:15, Hall D1
#SoMe #LCSM @SclcSMASHERS
@OncoAlert @OncBrothers
@PeerView @PortalOnconews @MedscapeOnc
@VJOncology @ecancer @LungCancerEu @YoungLungCancer @HeSMO_X @HenryDunantGR
Honoring Dr. Frances Shepherd, as she retires after six decades of advancing lung cancer research and patient care 🫁— a true pioneer, visionary leader, and deeply inspiring physician 🦸♀️🏆👸@TonyMok9 @CelineMascaux @karenkellymd
Jessica Menis retweeted
In this episode of Lung Cancer Considered, the @IASLC podcast, I discuss the current treatment considerations for advanced SCLC with Dr. Raffaele Califano and Dr. Jessica Menis. Listen below for the current state of the art! @caliraf @JessicaMenis
iaslc.org/iaslc-news/lung-ca…
Jessica Menis retweeted
Real world analysis of tarlatamab in SCLC (n=27) @JCOPO_ASCO: RR 18%, PFS 5.9m. Signs of CNS activity: in 14pts with brain mets, 2 CR & 1 PR; in 4pts with no baseline mets, none had new CNS mets. C1D1: CRS in 37%, ICANS in 30%. C1D8, CRS 40%, ICANS 16%.
ascopubs.org/doi/10.1200/PO-…
Jessica Menis retweeted
Farewell to another productive and exceptionally brainstorming @EORTC LCG meeting under the leadership and guidance of @JordiRemon @HendriksLizza @MarianaBrandao0
Huge 🙏 to Rafal Dziadziusco for a wonder honestly n beautiful Gdansk!!
See you all next year in Athens!!!!
Jessica Menis retweeted
Great discussions at the EORTC Lung Cancer Group meeting in Gdańsk. A real privilege to work with such a collaborative and forward-thinking community—especially encouraging to see new voices actively contributing to study design and research priorities. You are welcome!! #EORTC
Jessica Menis retweeted
Best way to start the @EORTC lung cancer group meeting here in #Gdansk with a fascinating symposium focusing on #SCLC with amazing lectures by @bartolomiej @finn_corinne and @NReguart , including a deep dive in SCLC biology
Jessica Menis retweeted
Fantastic presentation by Prof Jassem about roles of Pharma / Academia in drug development.
The strength of the EORTC Lung Cancer Group lies in its multidisciplinary to design academic studies with drugs developed by pharma aiming to identify optimal drug for groups of patients
EORTC LCG symposium at the start: amazing lecture of Prof Jacek Jassem
@JordiRemon @HendriksLizza @MarianaBrandao0 @NReguart @g_mountzios @finn_corinne @BenjaminBesseMD @RobertoFerrara_ @paolobironzo @elenaprisciandaro @AnnemarieDing @EORTC @rafaldziadziusko
Jessica Menis retweeted
Excited to be in Gdansk for the @EORTC Lung Cancer Group Spring Meeting. Proud to see so many early-career investigators leading discussions, challenging ideas, and shaping the future of thoracic oncology. The next generation is already here. #LungCancer #Oncology #EORTC
Jessica Menis retweeted
Should we do molec testing on all NSCLCs? Answer: YES @JTOonline
- 82328pts
- 35.1% AGA+ (adeno=45.8% adenosq=40.9% sarcomatoid=29.1% NOS=27.6%, LCC=21.1% sq=6.5%)
- age, sex, region assoc seen
Congrats @Al3ssandroRusso @ChristianRolfo @oncoalert #LCSM
jto.org/article/S1556-0864%2…
Jessica Menis retweeted
Our review on targeting MET in EGFRm NSCLC is out in @JTOonline! Always interesting to appreciate the similar challenges we face treating EGFRm lung cancer around the world. Thanks to all my co-authors, academia is much better with friends indeed ☺️
Proud to co-author our JTO @JTO_IASLC review on MET in EGFRm NSCLC! Thanks @stephanieplsaw for leading. Global work with wonderful friends @mollylisc @hiroto_pulm & mentors @MarianaBrandao0 @JordiRemon @HendriksLizza is why I stay in academia! 🌍 #LCSM jto.org/article/S1556-0864(2…
Jessica Menis retweeted
Looking forward to EORTC LCG spring meeting:Gdansk 16-18 April hosted by Pr Dziadziuszko & Dr Bandura + Young Early Career Investigators meeting on 16 April led by the fantastic @RobertoFerrara and Dr Prisciandaro. The future of EU🫁 oncology in EU is bright!Stay tuned⭐️⭐️@EORTC
Jessica Menis retweeted
Congrats to our own @ConorMoloneyOnc & #CarolineKinsella on their great contribution to the new @myesmo handbook:
‘Thoracic Tumours: Essentials for Clinicians’ on immunotherapy resistance in advanced NSCLC
Great work! 🇮🇪
@cancercentreire @cancertrials_ie #LCSM
Jessica Menis retweeted
A very moving and emotional opening session here in Copenhagen for #ELCC26 with the two chairs @DrSanjayPopat and @APassaroMD remembering and honoring two leaders that helped shaping modern thoracic oncology, Filippo de Marinis and Masahiro Tsuboi. Their legacy will be always remembered and cherished
@myESMO @IASLC
Jessica Menis retweeted
#ELCC26 loading!!! ➡️➡️➡️➡️
Ready to meet, interact and connect with great colleagues and friends from around the globe!!
@JessicaMenis @JordiRemon



















































